Examkin

Question

Difficulty: Very hardDisposition and Care Setting Transitions

A 75-year-old man with advanced ischemic cardiomyopathy is evaluated for hospital discharge following his third admission for acute decompensated heart failure in the past two months. Despite maximal optimization of guideline-directed medical therapy, he experiences intractable dyspnea at rest.

During this admission, his hemodynamics and dyspnea were stabilized only after initiating a continuous intravenous infusion of dobutamine. Two separate attempts to wean the dobutamine infusion resulted in immediate recurrent pulmonary edema and severe respiratory distress.

The patient is not a candidate for advanced heart failure therapies, such as a left ventricular assist device or heart transplantation, due to multiple severe medical comorbidities. During a family meeting, the patient is fully oriented and states, "I know my time is short. I just want to go back to my own house and be comfortable. I do not want any more aggressive treatments to try to fix my heart." His wife and adult daughter live with him and are fully capable of providing 24-hour physical assistance.

Which of the following is the most appropriate care setting transition for this patient?

  1. A
    Transfer to a skilled nursing facility for cardiopulmonary rehabilitation
  2. B
    Discharge home with comprehensive home health agency services
  3. C
    Transfer to a long-term acute care hospital for ongoing inotropic support
  4. Discharge home with routine hospice careAnswer
  5. E
    Transfer to a general inpatient hospice facility

Answer

Discharge home with routine hospice care
The correct disposition perfectly aligns the patient's medical needs, social support, and goals of care. The patient has end-stage heart failure with an estimated prognosis of less than six months and explicitly desires comfort care at home. A common misconception is that patients dependent on continuous intravenous inotropes cannot be discharged to a residential setting. However, when medications like dobutamine or milrinone are used for palliation (to relieve intractable dyspnea rather than as a bridge to transplant), routine home hospice agencies are fully equipped to manage these infusions. Because his symptoms are well-controlled on the current dose and he has capable family caregivers, he meets the criteria for routine home hospice care.

Step-by-Step Solution

1
Determine the patient's goals of care based on his clinical status and expressed wishes.
The patient has end-stage heart failure, is not a candidate for advanced therapies, and explicitly prioritizes comfort at home over life-prolonging treatment.
Establishing the overarching goal (palliative vs. restorative) dictates the entire trajectory of care setting transitions.
2
Evaluate the feasibility of managing the patient's current medical interventions in the preferred setting.
The patient is dependent on a continuous IV dobutamine infusion for symptom control (relief of dyspnea).
Some intensive treatments limit discharge options; however, palliative inotropes are a recognized exception that can be administered at home.
3
Synthesize the patient's goals, medical needs, and social support to select the precise disposition.
The patient's desire for comfort at home, presence of 24-hour family support, and need for palliative dobutamine make home hospice the perfect fit. General inpatient hospice is not indicated as his symptoms are currently stable on the infusion.
Matching the patient's clinical stability and psychosocial support with the correct tier of hospice care prevents inappropriate facility admissions.

Key Concept

Palliative continuous intravenous inotropes (e.g., dobutamine, milrinone) can be safely managed in the home setting by hospice agencies to provide symptom relief for patients with end-stage heart failure who wish to transition to comfort-focused care.
Rate this question

Topics

Disposition and Care Setting Transitions

More questions from this topic